A detailed history of Sabal Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Sabal Trust CO holds 222,345 shares of ABBV stock, worth $45.3 Million. This represents 2.27% of its overall portfolio holdings.

Number of Shares
222,345
Previous 228,791 2.82%
Holding current value
$45.3 Million
Previous $41.7 Million 8.46%
% of portfolio
2.27%
Previous 2.42%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$154.79 - $180.76 $997,776 - $1.17 Million
-6,446 Reduced 2.82%
222,345 $38.1 Million
Q1 2024

May 03, 2024

SELL
$159.82 - $182.1 $282,401 - $321,770
-1,767 Reduced 0.77%
228,791 $41.7 Million
Q4 2023

Jan 24, 2024

SELL
$137.6 - $154.97 $560,444 - $631,192
-4,073 Reduced 1.74%
230,558 $35.7 Million
Q3 2023

Oct 10, 2023

SELL
$133.59 - $154.65 $211,472 - $244,810
-1,583 Reduced 0.67%
234,631 $35 Million
Q2 2023

Jul 20, 2023

BUY
$132.51 - $164.9 $7.22 Million - $8.98 Million
54,473 Added 29.97%
236,214 $31.8 Million
Q1 2023

Apr 26, 2023

SELL
$144.61 - $166.54 $114,675 - $132,066
-793 Reduced 0.43%
181,741 $29 Million
Q4 2022

Jan 31, 2023

SELL
$138.31 - $165.87 $377,862 - $453,156
-2,732 Reduced 1.47%
182,534 $29.5 Million
Q3 2022

Oct 18, 2022

BUY
$134.21 - $153.93 $1.05 Million - $1.2 Million
7,813 Added 4.4%
185,266 $24.9 Million
Q2 2022

Jul 18, 2022

BUY
$137.62 - $174.96 $24.4 Million - $31 Million
177,453 New
177,453 $27.2 Million
Q1 2022

Apr 14, 2022

SELL
$131.98 - $163.75 $22.7 Million - $28.2 Million
-172,038 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$107.43 - $135.93 $17.6 Million - $22.3 Million
163,837 Added 1997.77%
172,038 $23.3 Million
Q2 2021

Jul 16, 2021

SELL
$105.21 - $117.21 $14,834 - $16,526
-141 Reduced 1.69%
8,201 $925,000
Q1 2021

Apr 19, 2021

BUY
$102.3 - $112.62 $2,046 - $2,252
20 Added 0.24%
8,342 $903,000
Q4 2020

Jan 20, 2021

SELL
$80.49 - $108.67 $263,926 - $356,328
-3,279 Reduced 28.26%
8,322 $891,000
Q3 2020

Oct 14, 2020

BUY
$85.91 - $100.83 $4,810 - $5,646
56 Added 0.49%
11,601 $1.02 Million
Q2 2020

Jul 13, 2020

SELL
$73.37 - $98.18 $88,851 - $118,895
-1,211 Reduced 9.49%
11,545 $1.13 Million
Q1 2020

Apr 14, 2020

BUY
$64.5 - $97.79 $33,604 - $50,948
521 Added 4.26%
12,756 $972,000
Q4 2019

Jan 14, 2020

SELL
$72.13 - $90.25 $46,235 - $57,850
-641 Reduced 4.98%
12,235 $1.08 Million
Q2 2019

Jul 17, 2019

SELL
$65.7 - $83.98 $94,936 - $121,351
-1,445 Reduced 10.09%
12,876 $936,000
Q1 2019

Apr 12, 2019

SELL
$77.14 - $90.79 $317,585 - $373,782
-4,117 Reduced 22.33%
14,321 $1.15 Million
Q4 2018

Feb 01, 2019

SELL
$77.85 - $96.01 $96,845 - $119,436
-1,244 Reduced 6.32%
18,438 $1.7 Million
Q3 2018

Oct 16, 2018

SELL
$88.91 - $98.84 $24.1 Million - $26.8 Million
-270,658 Reduced 93.22%
19,682 $1.86 Million
Q2 2018

Jul 16, 2018

BUY
$89.78 - $106.23 $1.57 Million - $1.86 Million
17,473 Added 6.4%
290,340 $26.9 Million
Q1 2018

Apr 16, 2018

SELL
$92.01 - $123.21 $4.25 Million - $5.69 Million
-46,187 Reduced 14.48%
272,867 $25.8 Million
Q4 2017

Feb 07, 2018

SELL
$89.56 - $98.21 $2.36 Million - $2.59 Million
-26,388 Reduced 7.64%
319,054 $30.9 Million
Q3 2017

Oct 17, 2017

BUY
$69.85 - $89.22 $24.1 Million - $30.8 Million
345,442
345,442 $30.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sabal Trust CO Portfolio

Follow Sabal Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabal Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Sabal Trust CO with notifications on news.